Viewing Study NCT04701060

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-03-15 @ 3:15 PM
Study NCT ID: NCT04701060
Status: COMPLETED
Last Update Posted: 2024-12-03
First Post: 2021-01-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Camrelizumab Combined With Apatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Resectable Hepatocellular Carcinoma View
Keywords: